Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
|
1 |
Issuer |
Oxford BioMedica PLC |
|
2 |
Reason for notification |
Notification relates to DTR 3.1.2R |
|
3 |
Name of PDMR |
Martin Diggle |
|
4 |
Connected person |
Notification relates to following connected persons: Vulpes Testudo Fund Vulpes Life Sciences Fund |
|
5 |
Notification in respect of |
Notification in respect of holdings of persons in 4 above |
|
6 |
Description of shares |
Oxford BioMedica PLC ordinary shares of 1p each |
|
7 |
Name of registered shareholders and number of shares |
Vulpes Testudo Fund - 85,797,333 shares Vulpes Life Sciences Fund - 447,452,767 shares |
|
8 |
Nature of transaction |
Disposal |
|
9 |
Number of shares acquired |
N/A |
|
10 |
Percentage of issued class acquired |
N/A |
|
11 |
Shares disposed |
Vulpes Testudo Fund - 85,797,333 shares |
|
12 |
Percentage of issued class disposed |
Vulpes Testudo Fund - 3.34% |
|
13/14 |
Price per share of transactions, and date |
Vulpes Testudo Fund 85,797,333 shares @ £0.05 , 12 December 2014 |
|
15 |
Total holding following notification and total percentage holding following notification |
Vulpes Life Sciences Fund - 447,452,767 shares 17.44% |
|
16 |
Date issuer informed |
12 December 2014 |
|
23 |
Any additional information |
None |
|
24 |
Contact name and telephone number |
T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
This information is provided by RNS